TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1

TUG1 knockdown ameliorates atherosclerosis by modulating FGF1 via miR-133a, raising the possibility of targeting TUG1 as an atheroprotective therapeutic strategy.